Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Jose Maria Zuazo Morquecho

Jose Maria Zuazo Morquecho

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca
Jose Maria Zuazo Morquecho

Jose Maria Zuazo Morquecho

Jose Maria Zuazo Morquecho

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Related news

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

See more

Related professionals

Sara Albarral Perez

Sara Albarral Perez

Administrative
Purchase and Biddings Unit
Finance Directorate
Read more
Silvia Sauleda Oliveras

Silvia Sauleda Oliveras

Transfusional Medicine
Read more
Lucía Rodriguez Diez

Lucía Rodriguez Diez

Predoctoral researcher
Rheumatology
Read more
Silvia Ferrer López

Silvia Ferrer López

Administration and Management
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.